 | • レポートコード：QY20ST-01612 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の生ワクチン市場について種類別（一価生ワクチン、多価生ワクチン）、用途別（成人、子供）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・生ワクチン市場の概要 ・世界の主要地域別生ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の生ワクチン市場規模2015-2026：種類別（一価生ワクチン、多価生ワクチン） ・世界の生ワクチン市場規模2015-2026：用途別（成人、子供） ・生ワクチンの北米市場規模2015-2020 ・生ワクチンのヨーロッパ市場規模2015-2020 ・生ワクチンの中国市場規模2015-2020 ・生ワクチンの日本市場規模2015-2020 ・生ワクチンの東南アジア市場規模2015-2020 ・生ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・生ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・生ワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Live Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Live Vaccines market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Live vaccine is bacterium or virus to make its mutation in artificial condition, lose pathogenicity but retain immunogenicity and reproduction ability and remaining virulence, after vaccinating, there is the reproduction or replication of certain level inside human body, resemble a light natural infection process, but won’t cause a person to come on.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Live Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Live Vaccines industry.
Based on our recent survey, we have several different scenarios about the Live Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Live Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Live Vaccines market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Live Vaccines market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Live Vaccines market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Live Vaccines market. The report also includes nautical information, where it shows Live Vaccines market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Live Vaccines market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Live Vaccines market.
Geographical Analysis:
Based on region, the global Live Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Live Vaccines market are
Merck
GlaxoSmithKline
Pfizer
Novartis
Astellas Pharma
Emergent BioSolutions
AstraZeneca
…
Segment by Type
Monovalent Live Vaccines
Multivalent Live Vaccines
Segment by Application
Adults
Children
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Live Vaccines market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Live Vaccines market.
• The market share of the global Live Vaccines market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Live Vaccines market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Live Vaccines market.
1 Live Vaccines Market Overview
1.1 Live Vaccines Product Scope
1.2 Live Vaccines Segment by Type
1.2.1 Global Live Vaccines Sales by Type (2020-2026)
1.2.2 Monovalent Live Vaccines
1.2.3 Multivalent Live Vaccines
1.3 Live Vaccines Segment by Application
1.3.1 Global Live Vaccines Sales Comparison by Application (2020-2026)
1.3.2 Adults
1.3.3 Children
1.4 Live Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Live Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Live Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Live Vaccines Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Live Vaccines Industry Impact
1.5.1 How the Covid-19 is Affecting the Live Vaccines Industry
1.5.1.1 Live Vaccines Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Live Vaccines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Live Vaccines Players to Combat Covid-19 Impact
2 Live Vaccines Estimate and Forecast by Region
2.1 Global Live Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Live Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Live Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Live Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Live Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Live Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Live Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Live Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Live Vaccines Estimates and Projections (2015-2026)
2.4.3 China Live Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Live Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Live Vaccines Estimates and Projections (2015-2026)
2.4.6 India Live Vaccines Estimates and Projections (2015-2026)
3 Global Live Vaccines Competition Landscape by Players
3.1 Global Top Live Vaccines Players by Sales (2015-2020)
3.2 Global Top Live Vaccines Players by Revenue (2015-2020)
3.3 Global Live Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Live Vaccines as of 2019)
3.4 Global Live Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Live Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Live Vaccines Players (Opinion Leaders)
4 Global Live Vaccines Market Size by Type
4.1 Global Live Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global Live Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global Live Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global Live Vaccines Price by Type (2014-2020)
4.2 Global Live Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Live Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Live Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global Live Vaccines Price Forecast by Type (2021-2026)
5 Global Live Vaccines Market Size by Application
5.1 Global Live Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global Live Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global Live Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global Live Vaccines Price by Application (2015-2020)
5.2 Global Live Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Live Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Live Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Live Vaccines Price Forecast by Application (2021-2026)
3 North America Live Vaccines Market Facts & Figures
3.2 North America Live Vaccines Sales Market Share by Company (2015-2020)
3.3 North America Live Vaccines Sales Market Share by Type (2015-2020)
3.4 North America Live Vaccines Sales Market Share by Application (2015-2020)
4 Europe Live Vaccines Market Facts & Figures
4.2 Europe Live Vaccines Sales Market Share by Company (2015-2020)
4.3 Europe Live Vaccines Sales Market Share by Type (2015-2020)
4.4 Europe Live Vaccines Sales Market Share by Application (2015-2020)
5 China Live Vaccines Market Facts & Figures
5.2 China Live Vaccines Sales Market Share by Company (2015-2020)
5.3 China Live Vaccines Sales Market Share by Type (2015-2020)
5.4 China Live Vaccines Sales Market Share by Application (2015-2020)
6 Japan Live Vaccines Market Facts & Figures
6.2 Japan Live Vaccines Sales Market Share by Company (2015-2020)
6.3 Japan Live Vaccines Sales Market Share by Type (2015-2020)
6.4 Japan Live Vaccines Sales Market Share by Application (2015-2020)
7 Southeast Asia Live Vaccines Market Facts & Figures
7.2 Southeast Asia Live Vaccines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Live Vaccines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Live Vaccines Sales Market Share by Application (2015-2020)
8 India Live Vaccines Market Facts & Figures
8.2 India Live Vaccines Sales Market Share by Company (2015-2020)
8.3 India Live Vaccines Sales Market Share by Type (2015-2020)
8.4 India Live Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Live Vaccines Business
12.1 Merck
12.1.1 Merck Live Vaccines Corporation Information
12.1.2 Merck Live Vaccines Business Overview and Total Revenue
12.1.3 Merck Live Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Live Vaccines Products Offered
12.1.5 Merck Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Live Vaccines Corporation Information
12.2.2 GlaxoSmithKline Live Vaccines Business Overview and Total Revenue
12.2.3 GlaxoSmithKline Live Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GlaxoSmithKline Live Vaccines Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Pfizer
12.3.1 Pfizer Live Vaccines Corporation Information
12.3.2 Pfizer Live Vaccines Business Overview and Total Revenue
12.3.3 Pfizer Live Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Live Vaccines Products Offered
12.3.5 Pfizer Recent Development
12.4 Novartis
12.4.1 Novartis Live Vaccines Corporation Information
12.4.2 Novartis Live Vaccines Business Overview and Total Revenue
12.4.3 Novartis Live Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis Live Vaccines Products Offered
12.4.5 Novartis Recent Development
12.5 Astellas Pharma
12.5.1 Astellas Pharma Live Vaccines Corporation Information
12.5.2 Astellas Pharma Live Vaccines Business Overview and Total Revenue
12.5.3 Astellas Pharma Live Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Astellas Pharma Live Vaccines Products Offered
12.5.5 Astellas Pharma Recent Development
12.6 Emergent BioSolutions
12.6.1 Emergent BioSolutions Live Vaccines Corporation Information
12.6.2 Emergent BioSolutions Live Vaccines Business Overview and Total Revenue
12.6.3 Emergent BioSolutions Live Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Emergent BioSolutions Live Vaccines Products Offered
12.6.5 Emergent BioSolutions Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Live Vaccines Corporation Information
12.7.2 AstraZeneca Live Vaccines Business Overview and Total Revenue
12.7.3 AstraZeneca Live Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 AstraZeneca Live Vaccines Products Offered
12.7.5 AstraZeneca Recent Development
…
13 Live Vaccines Manufacturing Cost Analysis
13.1 Live Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Live Vaccines
13.4 Live Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Live Vaccines Distributors List
14.3 Live Vaccines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Live Vaccines Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Live Vaccines Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Live Vaccines Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Live Vaccines Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Live Vaccines Players to Combat Covid-19 Impact
Table 8. Global Market Live Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Live Vaccines Sales (K Doses) by Region (2015-2020)
Table 10. Global Live Vaccines Sales Market Share by Region (2015-2020)
Table 11. Global Live Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Live Vaccines Revenue Share by Region (2015-2020)
Table 13. Global Live Vaccines Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Live Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Live Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Live Vaccines Revenue Share Forecast by Region (2021-2026)
Table 17. Global Live Vaccines (K Doses) of Key Companies (2015-2020)
Table 18. Global Live Vaccines Sales Share by Company (2015-2020)
Table 19. Global Live Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Live Vaccines Revenue Share by Company (2015-2020)
Table 21. Global Live Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Live Vaccines as of 2019)
Table 22. Global Live Vaccines Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Live Vaccines Manufacturing Sites and Area Served
Table 24. Manufacturers Live Vaccines Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Live Vaccines Players
Table 27. Global Live Vaccines Sales (K Doses) by Type (2015-2020)
Table 28. Global Live Vaccines Sales Share by Type (2015-2020)
Table 29. Global Live Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Live Vaccines Price (K Doses) by Type (2015-2020)
Table 31. Global Live Vaccines Sales Share by Type (2021-2026)
Table 32. Global Live Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Live Vaccines Revenue Share by Type (2021-2026)
Table 34. Global Live Vaccines Price (K Doses) by Type (2021-2026)
Table 35. Global Live Vaccines Sales (K Doses) by Application (2015-2020)
Table 36. Global Live Vaccines Sales Share by Application (2015-2020)
Table 37. Global Live Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Live Vaccines Price (K Doses) by Application (2015-2020)
Table 39. Global Live Vaccines Sales (K Doses) by Application (2021-2026)
Table 40. Global Live Vaccines Sales Share by Application (2021-2026)
Table 41. Global Live Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Live Vaccines Revenue Share by Application (2021-2026)
Table 43. Global Live Vaccines Price (K Doses) by Application (2021-2026)
Table 44. United States Live Vaccines Sales (K Doses) by Company (2015-2020)
Table 45. United States Live Vaccines Sales Market Share by Company (2015-2020)
Table 46. United States Live Vaccines Sales (K Doses) by Type (2015-2020)
Table 47. United States Live Vaccines Sales Market Share by Type (2015-2020)
Table 48. United States Live Vaccines Sales (K Doses) by Application (2015-2020)
Table 49. United States Live Vaccines Sales Market Share by Application (2015-2020)
Table 50. Europe Live Vaccines Sales (K Doses) by Company (2015-2020)
Table 51. Europe Live Vaccines Sales Market Share by Company (2015-2020)
Table 52. Europe Live Vaccines Sales (K Doses) by Type (2015-2020)
Table 53. Europe Live Vaccines Sales Market Share by Type (2015-2020)
Table 54. Europe Live Vaccines Sales (K Doses) by Application (2015-2020)
Table 55. Europe Live Vaccines Sales Market Share by Type (2015-2020)
Table 56. China Live Vaccines Sales (K Doses) by Company (2015-2020)
Table 57. China Live Vaccines Sales Market Share by Company (2015-2020)
Table 58. China Live Vaccines Sales (K Doses) by Type (2015-2020)
Table 59. China Live Vaccines Sales Market Share by Type (2015-2020)
Table 60. China Live Vaccines Sales (K Doses) by Application (2015-2020)
Table 61. China Live Vaccines Sales Market Share by Application (2015-2020)
Table 62. Japan Live Vaccines Sales (K Doses) by Company (2015-2020)
Table 63. Japan Live Vaccines Sales Market Share by Company (2015-2020)
Table 64. Japan Live Vaccines Sales (K Doses) by Type (2015-2020)
Table 65. Japan Live Vaccines Sales Market Share by Type (2015-2020)
Table 66. Japan Live Vaccines Sales (K Doses) by Application (2015-2020)
Table 67. Japan Live Vaccines Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Live Vaccines Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Live Vaccines Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Live Vaccines Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Live Vaccines Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Live Vaccines Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Live Vaccines Sales Market Share by Application (2015-2020)
Table 74. India Live Vaccines Sales (K Doses) by Company (2015-2020)
Table 75. India Live Vaccines Sales Market Share by Company (2015-2020)
Table 76. India Live Vaccines Sales (K Doses) by Type (2015-2020)
Table 77. India Live Vaccines Sales Market Share by Type (2015-2020)
Table 78. India Live Vaccines Sales (K Doses) by Application (2015-2020)
Table 79. India Live Vaccines Sales Market Share by Application (2015-2020)
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Live Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Merck Live Vaccines Product
Table 84. Merck Recent Development
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Live Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. GlaxoSmithKline Live Vaccines Product
Table 89. GlaxoSmithKline Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Live Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Pfizer Live Vaccines Product
Table 94. Pfizer Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Live Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Novartis Live Vaccines Product
Table 99. Novartis Recent Development
Table 100. Astellas Pharma Corporation Information
Table 101. Astellas Pharma Description and Business Overview
Table 102. Astellas Pharma Live Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Astellas Pharma Live Vaccines Product
Table 104. Astellas Pharma Recent Development
Table 105. Emergent BioSolutions Corporation Information
Table 106. Emergent BioSolutions Description and Business Overview
Table 107. Emergent BioSolutions Live Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Emergent BioSolutions Live Vaccines Product
Table 109. Emergent BioSolutions Recent Development
Table . AstraZeneca Corporation Information
Table . AstraZeneca Description and Business Overview
Table . AstraZeneca Live Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . AstraZeneca Live Vaccines Product
Table . AstraZeneca Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Live Vaccines Distributors List
Table 118. Live Vaccines Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Live Vaccines Product Picture
Figure 2. Global Live Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Live Vaccines Market Share by Application in 2020 & 2026
Figure 6. Adults Examples
Figure 7. Children Examples
Figure 8. Global Live Vaccines Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Live Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Live Vaccines Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global Live Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Live Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Live Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Live Vaccines Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Live Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Live Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Live Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Live Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Live Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Live Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Live Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Live Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Live Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Live Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Live Vaccines Players Market Share by Revenue in Live Vaccines 2015 & 2019
Figure 26. Live Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Live Vaccines Revenue Share by Type (2015-2020)
Figure 28. Global Live Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Live Vaccines Revenue Share by Application (2015-2020)
Figure 30. Global Live Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Live Vaccines Sales Market Share by Type in 2019
Figure 32. United States Live Vaccines Sales Market Share by Type in 2019
Figure 33. Europe Live Vaccines Sales Market Share by Company in 2019
Figure 34. Europe Live Vaccines Sales Market Share by Type in 2019
Figure 35. Europe Live Vaccines Sales Market Share by Application in 2019
Figure 36. China Live Vaccines Sales Market Share by Company in 2019
Figure 37. China Live Vaccines Sales Market Share by Type in 2019
Figure 38. China Live Vaccines Sales Market Share by Application in 2019
Figure 39. Japan Live Vaccines Sales Market Share by Company in 2019
Figure 40. Japan Live Vaccines Sales Market Share by Type in 2019
Figure 41. Japan Live Vaccines Sales Market Share by Application in 2019
Figure 42. Southeast Asia Live Vaccines Sales Market Share by Company in 2019
Figure 43. Southeast Asia Live Vaccines Sales Market Share by Type in 2019
Figure 44. Southeast Asia Live Vaccines Sales Market Share by Application in 2019
Figure 45. India Live Vaccines Sales Market Share by Company in 2019
Figure 46. India Live Vaccines Sales Market Share by Type in 2019
Figure 47. India Live Vaccines Sales Market Share by Application in 2019
Figure 48. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Emergent BioSolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Live Vaccines
Figure 57. Manufacturing Process Analysis of Live Vaccines
Figure 58. Live Vaccines Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
水痘生ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Varicella Live Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accu…- 豚流行性下痢ワクチンの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Swine Epidemic Diarrhea Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- 犬用ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Dog Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data …
- 猫用ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Cat Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data …
- デング熱ワクチンの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Dengue Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dengue Vaccines market report…